PDE5A and diabetes mellitus: Through a comprehensive synthesis of existing clinical trials, we aim to provide a deeper understanding of PDE5 inhibitors' potential in improving glycaemic control among individuals with diabetes, shedding light on its implications for both clinical practice and future research endeavours.